Search results
Ultragenyx (RARE) Posts Data From Osteogenesis Imperfecta Study
Zacks via Yahoo Finance· 11 months agoUltragenyx (RARE), along with partner Mereo BioPharma, announces encouraging data on mid-stage study...
What Causes Scoliosis?
Verywell Health via Yahoo News· 9 months agoA Closer Look at the Underlying Pathology in Children and AdultsMedically reviewed by Josephine Hessert, DO Scoliosis is an abnormal curvature of the...
Ultragenyx's (RARE) Q2 Earnings Miss Estimates, Revenues Up
Zacks via Yahoo Finance· 2 years agoUltragenyx Pharmaceutical Inc. RARE incurred a loss of $2.26 per share in second-quarter 2022, wider...
Minnesota musicians share how disabilities elevate art and culture
Post-Bulletin, Rochester, Minn. via Yahoo News· 7 months agoOct. 29—ROCHESTER — Gaelynn Lea was born with osteogenesis imperfecta, a genetic condition that causes complications in the development of bones and limbs. As a result, when she learned to play ...
Ultragenyx (RARE) Doses First Patients in Bone Disease Studies
Zacks via Yahoo Finance· 10 months agoUltragenyx (RARE) announces dosing the first patients in its phase III studies evaluating setrusumab...
Mereo BioPharma (MREO) Up as AstraZeneca Reportedly Eyes Buyout
Zacks via Yahoo Finance· 2 years agoShares of small-biotech Mereo BioPharma MREO surged 62.5% on Jun 17, following a report issued by...
Ultragenyx Pharmaceutical Inc (RARE) Reports Q3 2023 Earnings: Revenue Grows by 8% Year-Over-Year
GuruFocus.com via Yahoo Finance· 6 months agoUltragenyx Pharmaceutical Inc (NASDAQ:RARE) reported Q3 2023 total revenue of $98.1 million, marking...
Ultragenyx Pharmaceutical Inc (RARE) Q1 2024 Earnings: Misses EPS Estimates, Revenue Grows ...
GuruFocus.com via Yahoo Finance· 2 weeks agoTotal Revenue: Reported $109 million in Q1 2024, an 8% increase year-over-year, falling short of the...
Orthofix Medical's (OFIX) Telescopic Nail Gets FDA Clearance
Zacks via Yahoo Finance· 3 days agoOrthofix Medical (OFIX) announces the FDA clearance of its Rodeo Telescopic Nail, which is likely to...
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q4 2022 Earnings Call Transcript February 16, 2023...